Newborn screening of metabolic disorders: Recent progress and future developments

P. Rinaldo, J. Lim, S. Tortorelli, D. Gavrilov, D. Matern

Research output: Chapter in Book/Report/Conference proceedingConference contribution

19 Citations (Scopus)

Abstract

Tandem mass spectrometry has been the main driver behind a significant expansion in newborn screening programs. The ability to detect more than 40 conditions by a single test underscores the need to better understand the clinical and laboratory characteristics of the conditions being tested, and the complexity of pattern recognition and differential diagnoses of one or more elevated markers. The panel of conditions recommended by the American College of Medical Genetics, including 20 primary conditions and 22 secondary targets that are detectable by tandem mass spectrometry has been adopted as the standard of care in the vast majority of US states. The evolution of newborn screening is far from being idle as a large number of infectious, genetic, and metabolic conditions are currently under investigation at variable stages of test development and clinical validation. In the US, a formal process with oversight by the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children has been established for nomination and evidence-based review of new candidate conditions. If approved, these conditions could be added to the uniform panel and consequently pave the way to large scale implementation.

Original languageEnglish (US)
Title of host publicationNestle Nutrition Workshop Series: Pediatric Program
Pages81-93
Number of pages13
Volume62
DOIs
StatePublished - 2008

Publication series

NameNestle Nutrition Workshop Series: Pediatric Program
Volume62
ISSN (Print)16616677
ISSN (Electronic)16623878

Fingerprint

metabolic diseases
neonates
Newborn Infant
Tandem Mass Spectrometry
screening
Inborn Genetic Diseases
genetic disorders
Advisory Committees
Standard of Care
committees
Differential Diagnosis
testing
tandem mass spectrometry

ASJC Scopus subject areas

  • Food Science
  • Pediatrics, Perinatology, and Child Health
  • Nutrition and Dietetics

Cite this

Rinaldo, P., Lim, J., Tortorelli, S., Gavrilov, D., & Matern, D. (2008). Newborn screening of metabolic disorders: Recent progress and future developments. In Nestle Nutrition Workshop Series: Pediatric Program (Vol. 62, pp. 81-93). (Nestle Nutrition Workshop Series: Pediatric Program; Vol. 62). https://doi.org/10.1159/000146253

Newborn screening of metabolic disorders : Recent progress and future developments. / Rinaldo, P.; Lim, J.; Tortorelli, S.; Gavrilov, D.; Matern, D.

Nestle Nutrition Workshop Series: Pediatric Program. Vol. 62 2008. p. 81-93 (Nestle Nutrition Workshop Series: Pediatric Program; Vol. 62).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Rinaldo, P, Lim, J, Tortorelli, S, Gavrilov, D & Matern, D 2008, Newborn screening of metabolic disorders: Recent progress and future developments. in Nestle Nutrition Workshop Series: Pediatric Program. vol. 62, Nestle Nutrition Workshop Series: Pediatric Program, vol. 62, pp. 81-93. https://doi.org/10.1159/000146253
Rinaldo P, Lim J, Tortorelli S, Gavrilov D, Matern D. Newborn screening of metabolic disorders: Recent progress and future developments. In Nestle Nutrition Workshop Series: Pediatric Program. Vol. 62. 2008. p. 81-93. (Nestle Nutrition Workshop Series: Pediatric Program). https://doi.org/10.1159/000146253
Rinaldo, P. ; Lim, J. ; Tortorelli, S. ; Gavrilov, D. ; Matern, D. / Newborn screening of metabolic disorders : Recent progress and future developments. Nestle Nutrition Workshop Series: Pediatric Program. Vol. 62 2008. pp. 81-93 (Nestle Nutrition Workshop Series: Pediatric Program).
@inproceedings{586c86ac7b34404d8ae3809e0ad398ac,
title = "Newborn screening of metabolic disorders: Recent progress and future developments",
abstract = "Tandem mass spectrometry has been the main driver behind a significant expansion in newborn screening programs. The ability to detect more than 40 conditions by a single test underscores the need to better understand the clinical and laboratory characteristics of the conditions being tested, and the complexity of pattern recognition and differential diagnoses of one or more elevated markers. The panel of conditions recommended by the American College of Medical Genetics, including 20 primary conditions and 22 secondary targets that are detectable by tandem mass spectrometry has been adopted as the standard of care in the vast majority of US states. The evolution of newborn screening is far from being idle as a large number of infectious, genetic, and metabolic conditions are currently under investigation at variable stages of test development and clinical validation. In the US, a formal process with oversight by the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children has been established for nomination and evidence-based review of new candidate conditions. If approved, these conditions could be added to the uniform panel and consequently pave the way to large scale implementation.",
author = "P. Rinaldo and J. Lim and S. Tortorelli and D. Gavrilov and D. Matern",
year = "2008",
doi = "10.1159/000146253",
language = "English (US)",
isbn = "9783805585538",
volume = "62",
series = "Nestle Nutrition Workshop Series: Pediatric Program",
pages = "81--93",
booktitle = "Nestle Nutrition Workshop Series: Pediatric Program",

}

TY - GEN

T1 - Newborn screening of metabolic disorders

T2 - Recent progress and future developments

AU - Rinaldo, P.

AU - Lim, J.

AU - Tortorelli, S.

AU - Gavrilov, D.

AU - Matern, D.

PY - 2008

Y1 - 2008

N2 - Tandem mass spectrometry has been the main driver behind a significant expansion in newborn screening programs. The ability to detect more than 40 conditions by a single test underscores the need to better understand the clinical and laboratory characteristics of the conditions being tested, and the complexity of pattern recognition and differential diagnoses of one or more elevated markers. The panel of conditions recommended by the American College of Medical Genetics, including 20 primary conditions and 22 secondary targets that are detectable by tandem mass spectrometry has been adopted as the standard of care in the vast majority of US states. The evolution of newborn screening is far from being idle as a large number of infectious, genetic, and metabolic conditions are currently under investigation at variable stages of test development and clinical validation. In the US, a formal process with oversight by the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children has been established for nomination and evidence-based review of new candidate conditions. If approved, these conditions could be added to the uniform panel and consequently pave the way to large scale implementation.

AB - Tandem mass spectrometry has been the main driver behind a significant expansion in newborn screening programs. The ability to detect more than 40 conditions by a single test underscores the need to better understand the clinical and laboratory characteristics of the conditions being tested, and the complexity of pattern recognition and differential diagnoses of one or more elevated markers. The panel of conditions recommended by the American College of Medical Genetics, including 20 primary conditions and 22 secondary targets that are detectable by tandem mass spectrometry has been adopted as the standard of care in the vast majority of US states. The evolution of newborn screening is far from being idle as a large number of infectious, genetic, and metabolic conditions are currently under investigation at variable stages of test development and clinical validation. In the US, a formal process with oversight by the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children has been established for nomination and evidence-based review of new candidate conditions. If approved, these conditions could be added to the uniform panel and consequently pave the way to large scale implementation.

UR - http://www.scopus.com/inward/record.url?scp=49449092861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49449092861&partnerID=8YFLogxK

U2 - 10.1159/000146253

DO - 10.1159/000146253

M3 - Conference contribution

C2 - 18626194

SN - 9783805585538

VL - 62

T3 - Nestle Nutrition Workshop Series: Pediatric Program

SP - 81

EP - 93

BT - Nestle Nutrition Workshop Series: Pediatric Program

ER -